Additionally, upstream IRAK4 inhibition by highly selective novel small molecule inhibitors, ND-2158 and ND-2110, impeded survival of DLBCL cells by downregulating survival signals, including IL6/IL10/JAK/STAT3 [112]. Here, IL6 is linked to diffuse large B-cell lymphoma.